Recurrence of ovarian endometrioma after laparoscopic excision: Risk factors and prevention

Nozomi Ouchi, Ouchi N, Akira S, Shigeo Akira, Katsuya Mine, Mine K, Masao Ichikawa, Toshiyuki Takeshita, Takeshita T
Journal of Obstetrics and Gynaecology Research · 2013 · vol. 40(1) , pp. 230–236 · doi:10.1111/jog.12164 · PMID:24102958 · W1960935642
article OA: closed CC0 ⤵ 47 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This retrospective study found that age 32 years or younger was the primary risk factor for ovarian endometrioma recurrence after laparoscopic excision, with a recurrence rate up to 50% over five years in untreated patients.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

AIM: The aim of this study was to assess the cut-off age of the risk factors for postoperative recurrence of ovarian endometriomas and to evaluate the end-points of follow-up after laparoscopic excision of ovarian endometriomas. MATERIAL AND METHODS: We retrospectively reviewed 167 patients who underwent laparoscopic excision of ovarian endometriomas at our hospital between 2000 and 2009, and followed up the patients until 2010. Following surgery, patients chose to receive gonadotrophin-releasing hormone agonist, oral contraceptive pills (OCP), dienogest, or no medication and underwent regular ultrasonographic examinations. Potential risk factors for recurrence, including age at surgery, were assessed in the patients receiving no medication. Postoperative recurrence, defined as re-appearance of an ovarian endometrioma > 2 cm in size, was assessed for each treatment group. RESULTS: Age at surgery was the only significant risk factor for recurrence, at a cut-off of 32 years, obtained through receiver-operator curve analysis. In patients not receiving medication, the recurrence rate gradually increased up to 50% over 5 years; there was no recurrence 5 years after surgery. Although no recurrence was seen in patients during continuous treatment with OCP or dienogest, the disease recurred in 55.5% of patients after discontinuing OCP. CONCLUSIONS: Although adjuvant therapy for all patients may represent overtreatment, the findings of the present study suggest that, in the interest of fertility preservation, continuous postoperative hormonal treatment should be administered, at least to patients younger than 32 years. In patients who decline hormonal treatment, we recommend that they undergo follow-up for recurrence until 5 years after surgery.

My notes (saved in your browser only)

Condition tags

endometriosisendometrioma

MeSH descriptors

Endometriosis Ovarian Diseases Ovary Adult Endometriosis Endometriosis Endometriosis Female Follow-Up Studies Hospitals, University Humans Japan Japan Laparoscopy Ovarian Diseases Ovarian Diseases Ovarian Diseases Ovary Retrospective Studies Risk Factors

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (34)

Cited by (48)

Source provenance

europepmc
last seen: 2026-08-30T09:23:35.175841+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:18:47.062786+00:00
unpaywall
last seen: 2026-09-02T07:26:43.000666+00:00
License: CC0 · commercial use OK